Table 5.

Adverse events at any time during treatment

	Women		p	Men		p
	NTX N=29	PLC N=28		NTX N=78	PLC N=76
Nausea	38%	8%	0.01	13%	10%	0.82
Falling Asleep	24%	46%	0.09	23%	24%	0.77
Staying asleep	17%	54%	0.00	36%	31%	0.79
Decreased Appetite	17%	12%	0.56	25%	12%	0.09
Headache	48%	41%	0.47	34%	19%	0.08
Dizzy	7%	8%	0.91	13%	3%	0.09
Fatigue	52%	41%	0.33	31%	30%	0.93
Sexual Dysfunction	21%	35%	0.26	32%	35%	0.63

p is comparing NTX (naltrexone) to PLC (placebo).